KAD-1229

· Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KAD-1229, covering 2014-11-24 to 2019-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus [Phase 4]